A/S Novo Insider Trading $HTGM HTG MOLECULAR DIAGNOSTICS, INC
Get free email notifications about insider trading for A/S Novo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY).
A/S Novo in HTG MOLECULAR DIAGNOSTICS, INC
Trading Symbol: HTGMIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of A/S Novo: 10% Owner
Holdings: 1,102,651 shares
Current Value: $2,028,878
Latest Transaction: Aug 25 2017
$HTGM Market Capitalization: $12.65M
$HTGM Previous Close: $1.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of A/S Novo in HTG MOLECULAR DIAGNOSTICS, INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, ANAB, LPTN, BMTI, BOLT, CMPI, CLCD, CRVS, EAR, EWTX, ETTX, FLXN, GRTX, HRMY, HTGM, INGN, INZY, IRTC, OPHT, KALV, MIST, MIRM, MORF, NKTX, PRAX, RARX, RETA, RPHM, SPRB, TBRA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 25 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 1.75 | 720,214 | 1,260,591 | 0 | 720.2 K to 0 (-100.00 %) |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 1.91 | 382,437 | 729,919 | 720,214 | 1.1 M to 720.2 K (-34.68 %) |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.02 | 47,162 | 95,475 | 1,102,651 | 1.1 M to 1.1 M (-4.10 %) |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.01 | 12,641 | 25,412 | 1,199,599 | 1.2 M to 1.2 M (-1.04 %) |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.02 | 12,845 | 25,976 | 1,212,240 | 1.2 M to 1.2 M (-1.05 %) |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.10 | 55,100 | 115,600 | 1,225,085 | 1.3 M to 1.2 M (-4.30 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | X | 0.00 | 49,786 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 110,755 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 156,123 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 598,415 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | P | 14.00 | 365,106 | 5,111,484 | 1,280,185 | 915.1 K to 1.3 M (+39.90 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | X | 0.00 | 49,786 | 0 | 915,079 | 865.3 K to 915.1 K (+5.75 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 110,755 | 0 | 865,293 | 754.5 K to 865.3 K (+14.68 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 754,538 | 0 | 754,538 | 0 to 754.5 K |
Page: 1